scholarly journals Social Non-profit Bioentrepreneurship: Current Status and Future Impact on Global Health

2021 ◽  
Vol 9 ◽  
Author(s):  
Amir H. Sadeghi ◽  
Charlotte Koldeweij ◽  
Grissel Trujillo-de Santiago ◽  
Milad Tannazi ◽  
Nikkie Hosseinnia ◽  
...  
Keyword(s):  
Global Health ◽  
Business Strategy ◽  
Public Awareness ◽  
Current Status ◽  
Multidisciplinary Teams ◽  
Health Issues ◽  
Success Rates ◽  
Term Survival ◽  
Non Profit ◽  
For Profit

For-profit biotechnological and pharmaceutical companies have played an essential role in the research and development (R&D) of innovative medical products and drugs for many decades and embody a trillion-dollar industry. The past decades have been marked by an increase in growth of social non-profit biotechnology companies and organizations led by entrepreneurs committed to solve (global) health issues. In this review, we define the concept of social bioentrepreneurship and consider the potential impact of such ventures on global health. We analyse the current status of non-profit biotechnology and clarify the strategy, motivation, funding, and marketing techniques of these enterprises. We find that these non-profit ventures mainly focus on neglected and rare diseases by using different but also similar funding, marketing, and business strategy approaches to for-profit biotechnology enterprises. We also identify good leadership, multidisciplinary teams, and public awareness as key components to achieve long-term survival and higher success rates. Challenges faced by bioentrepreneurs include the lack of a clearly defined regulatory environment or governmental incentives to support their endeavors. Overall, with this qualitative data review and market analysis we draw a promising picture of social non-profit bioentrepreneurship and underscore its current and future impact on global health issues.

scholarly journals WIPO Re:Search—A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis

2019 ◽  
Vol 4 (1) ◽  
pp. 11 ◽  
Author(s):  
Callie J. Weber ◽  
Joseph Hargan-Calvopiña ◽  
Katy M. Graef ◽  
Cathyryne K. Manner ◽  
Jennifer Dent
Keyword(s):  
Chronic Disease ◽  
Global Health ◽  
Product Development ◽  
Research And Development ◽  
Mass Drug Administration ◽  
Early Stage ◽  
Neglected Diseases ◽  
Non Profit ◽  
For Profit ◽  
Two Sectors

Schistosomiasis is an acute and chronic disease that affects over 200 million people worldwide, and with over 700 million people estimated to be at risk of contracting this disease, it is a pressing issue in global health. However, research and development (R&D) to develop new approaches to preventing, diagnosing, and treating schistosomiasis has been relatively limited. Praziquantel, a drug developed in the 1970s, is the only agent used in schistosomiasis mass drug administration (MDA) campaigns, indicating a critical need for a diversified therapeutic pipeline. Further, gaps in the vaccine and diagnostic pipelines demonstrate a need for early-stage innovation in all areas of schistosomiasis product R&D. As a platform for public-private partnerships (PPPs), the WIPO Re:Search consortium engages the private sector in early-stage R&D for neglected diseases by forging mutually beneficial collaborations and facilitating the sharing of intellectual property (IP) assets between the for-profit and academic/non-profit sectors. The Consortium connects people, resources, and ideas to fill gaps in neglected disease product development pipelines by leveraging the strengths of these two sectors. Using WIPO Re:Search as an example, this article highlights the opportunities for the PPP model to play a key role in the elimination of schistosomiasis.

For-profit medical institutions in China: current status analysis and comparison with non-profit ones

2013 ◽  
Vol 5 (1) ◽  
pp. 37-47
Author(s):  
Lan Qiu ◽  
Yuanyuan Yu ◽  
Jingjing Liu ◽  
Hao Hu ◽  
Yitao Wang
Keyword(s):  
Current Status ◽  
Non Profit ◽  
For Profit ◽  
Medical Institutions ◽  
Status Analysis

scholarly journals Business Strategy analysis of Cybersecurity Incidents

2021 ◽  
Vol 26 (2) ◽  
pp. 139-148
Author(s):  
Zsolt Bederna ◽  
Zoltan Rajnai ◽  
Tamas Szadeczky
Keyword(s):  
Business Strategy ◽  
Decisive Role ◽  
Legal Framework ◽  
Strategy Formulation ◽  
Strategy Analysis ◽  
Non Profit ◽  
For Profit ◽  
Design Protection ◽  
Iterative Evolution ◽  
Risk Proportionate

Abstract In the current social and economic processes, information and communication services play a decisive role, changing several entities’ operations. The growing dependence that has developed over the last two decades made the security needs introduced political will, which has resulted in an iterative evolution of the regulatory environment. Hence, the legal framework requires that several entities develop protection that includes controls enhancing both preventive and reactive in a risk-proportionate manner under the business value to be protected. Nevertheless, due to the nature of cybersecurity, the development of such capabilities is not the task of a single organisation but all entities involved in cyberspace, including, e.g., individuals, non-profit and for-profit organisations, public sector actors. Therefore, each involved entity should design protection capabilities in a risk-proportionate manner, which requires strategic approaches and tools and requires organisations to learn from security incidents. This paper reviews the essential formal security strategy formulation tools, applying in the Facebook’s case based on publicly available information. The analysis aims to confirm the importance of management’s attitude and support for tackling cybersecurity’s challenges.

scholarly journals MEDICAID MANAGED LONG-TERM CARE PROGRAMS VS. THE TRADITIONAL MODEL: COMPARATIVE COSTS AND OUTCOMES

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S229-S229
Author(s):  
Larry Polivka
Keyword(s):  
Quality Of Care ◽  
Long Term Care ◽  
The State ◽  
Current Status ◽  
Term Care ◽  
Profit Model ◽  
Non Profit ◽  
For Profit

Abstract Several states have adopted Medicaid Managed Long-Term Care (MLTC) programs over the last several years. At this point at least 30 states are either administering such models or have plans to in the near future. We do not, however, know much yet about the relative cost-effectiveness of the MLTC model when compared to the traditional non-profit model of Medicaid LTC. Is the for-profit MLTC model actually generating savings in the Medicaid program while improving the quality of care? This symposia is designed to address the question through three presentations on experiences with MLTC programs in the states of Ohio, Texas and Pennsylvania and a fourth presentation offering a national overview and critique of Medicaid MLTC in comparison to the traditional Medicaid LTC program still administered through non-profit Aging Network organizations. The state focused presentations describe the current status and results of MLTC in three states that vary in their specific features, extent of formal accountability for outcomes and the political contexts in which the programs currently function. The presentations also include discussions of the implications of each states experiences for the future of Medicaid LTC policy at the state and federal levels. The fourth presentation is a critical analysis of the main differences between the traditional non-profit model of Medicaid LTC services and the for-profit MLTC programs in terms of commonly accepted criteria of cost-effective LTC services, such as access, quality of care and per-person costs and differences in the roles of advocacy and accountability.

China, International Society, and Global Health Governance

2018 ◽  
Author(s):  
Jeremy Youde
Keyword(s):  
Foreign Policy ◽  
Global Health ◽  
International Society ◽  
Global Health Governance ◽  
Health Issues ◽  
Governance System ◽  
Health Governance ◽  
Policy Tool ◽  
Governance Institutions ◽  
Ambivalent Relationship

China possesses the world’s largest economy, but that economic clout has not necessarily translated into taking leading roles within existing global health governance institutions and processes. It is a country that both contributes to and receives financial assistance from global health institutions. It has incorporated health into some of its foreign policy activities, but it has largely avoided proactively engaging with the values and norms embodied within the global health governance system. This ambivalent relationship reflects larger questions about how and whether China fits within international society and what its engagement or lack thereof might portend for international society’s future. This chapter examines China’s place within global health governance by examining its interactions with international society on global health issues, its use of health as a foreign policy tool, and its relationships with global health governance organizations.

The Role of the Business Sector in Global Health Politics

2018 ◽  
pp. 385-408
Author(s):  
Kelley Lee ◽  
Julia Smith
Keyword(s):  
Collective Action ◽  
Global Health ◽  
Business Sector ◽  
Policy Debate ◽  
Public And Private ◽  
Health Politics ◽  
For Profit ◽  
Goods And Services ◽  
Private Interests ◽  
Health Related

The influence of for-profit businesses in collective action across countries to protect and promote population health dates from the first International Sanitary Conferences of the nineteenth century. The restructuring of the world economy since the late twentieth century and the growth of large transnational corporations have led the business sector to become a key feature of global health politics. The business sector has subsequently moved from being a commercial producer of health-related goods and services, contractor, and charitable donor, to being a major shaper of, and even participant in, global health policymaking bodies. This chapter discusses three sites where this has occurred: collective action to regulate health-harming industries, activities to provide for public interest needs, and participation in decision-making within global health institutions. These changing forms of engagement by the business sector have elicited scholarly and policy debate regarding the appropriate relationship between public and private interests in global health.

scholarly journals A framework for identifying and learning from countries that demonstrated exemplary performance in improving health outcomes and systems

2020 ◽  
Vol 5 (12) ◽  
pp. e002938
Author(s):  
Austin Carter ◽  
Nadia Akseer ◽  
Kevin Ho ◽  
Oliver Rothschild ◽  
Niranjan Bose ◽  
...  
Keyword(s):  
Mixed Methods ◽  
Global Health ◽  
Health Outcomes ◽  
Mixed Methods Research ◽  
Multidisciplinary Teams ◽  
Ongoing Research ◽  
Qualitative And Quantitative ◽  
Success Stories ◽  
Quantitative Analyses ◽  
Comprehensive Framework

This paper introduces a framework for conducting and disseminating mixed methods research on positive outlier countries that successfully improved their health outcomes and systems. We provide guidance on identifying exemplar countries, assembling multidisciplinary teams, collecting and synthesising pre-existing evidence, undertaking qualitative and quantitative analyses, and preparing dissemination products for various target audiences. Through a range of ongoing research studies, we illustrate application of each step of the framework while highlighting key considerations and lessons learnt. We hope uptake of this comprehensive framework by diverse stakeholders will increase the availability and utilisation of rigorous and comparable insights from global health success stories.

Sign in / Sign up

Export Citation Format

Share Document